Sandoz Inc. is a multinational pharmaceutical company specializing in the production of generics (complete analogues of branded medicines).
The company has more than 24 thousand employees and is represented in 140 countries of the world including: Canada, USA, Australia, Argentina, England, Czech Republic, Spain, Ukraine, France, Russia and others. The headquarters (headquarters) are located in Holzkirchen, Bavaria, Germany. Over the years, the company has become one of the best in the development, production and supply of generics.
The history of the trademark began with a small company producing various chemicals, which was founded in Basel, Switzerland, in 1886. The first name is “Kern and Sandoz”. Initially, the company produced chemical dyes. The first pharmaceutical was released 10 years after the discovery – it was a means to reduce heat, antipyrine. The first department of pharmaceutics was established in 1917, after 12 years the company produced its own drug – “Calcium Sandoz”. This was a solid step for calcium therapy. This drug remains one of the most famous drugs to this day.
“Kern and Santos” became Santos Ltd. in 1939, having existed with this name for almost 60 years. In the same period, after the war, in 1951, in Austria, Biochemie was founded. The company produced and delivered extremely rare at that time penicillin. During the same period, scientists from the “Biochemi” invented a penicillin resistant to chemicals. Thanks to this in the future, the staff realized a great success. Sandoz acquired the rights to Biochemie GmbH in 1963, initiating the mass production of antibiotics.
Sandoz is a division of the Novartis brand, leading the world leadership in the field of generic medicinal products and bio-analogs. The unit was founded in 2003, at that time Novartis merged all the generic production groups into one, which acquired its current name. Since then, the company has developed into the world’s leading manufacturer of generic drugs with annual revenue from sales of more than 10 billion US dollars. The corporation is an indicator of quality, as health care professionals around the world trust him as a supplier of quality and affordable medicines.
Today’s activities of the organization are aimed at:
The Corporation takes the leading place in the world among manufacturers of antibiotics and bio-analogs, medicines created to treat skin diseases and conduct transplants. In addition, the corporation is leading in the areas of treatment and prevention of nervous and cardiovascular systems. The company also develops painkillers.
A wide range of products includes the drug “Omnitrope”, which is an analogue of somatotropin. The use of omnitrops stimulates the growth of bones and muscles, improving the quality of their structure, activating metabolic processes. Also, the drug positively affects the strength indicators, improves endurance.
In the 20th century, the brand continued to grow, eventually gaining worldwide recognition. In 1996, through the combination of Sandoz and Giba-Geigy, the trademark Novartis was created. The original name was not used for several years, without losing for this time its recognition from professionals. The name was renewed after 7 years, when Navartis decided to combine all global generic manufacturing enterprises into one.
Beginning in Basel in the 19th century, “Sandoz” step by step turned into a recognized leader in the production of generics and biosimulators. To date, the brand offers about 1,000 molecules that cover a wide range of medical fields.
The company has a huge scientific base, which allows it to break out into the leaders in the world medical race. It was here that the first bioanalogues were made, innovative methods of transplantation of medicinal substances were developed. The corporation is beyond the bounds of manufacturing standard drugs, increasing the effectiveness of the global health system. This is facilitated by the provision of additional services and substances with unique, useful properties.
The daily activity of the organization is directly related to the expansion of access to medicine. The corporation introduces a number of programs aimed at providing health services to the least protected and secured layers of humanity. The brand aims to expand access to medical services and information around the world, creating the conditions for development. “Sandoz” make high-quality medicine more accessible.
Showing all 2 results
|1 – 30 IU cartridges (10 MG) (1 Kit)||$100.00||$100.00|
|5 – 30 IU cartridges (10 MG) (3 Kits)||$95.00||$475.00|
|10 – 30 IU cartridges (10 MG) (6 Kits)||$93.00||$930.00|
|1 – Omnitrope Pen 10||$25.00||$25.00|